Evidence map›Paper›PMID 28438024›Full record

ReviewBiointerphases2017

Biomedical surface analysis: Evolution and future directions (Review).

David G Castner

Abstract readReview
In one paragraph

Review in Biointerphases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. ToF-SIMS analysis of ultrathin films and their fragmentation patterns.Journal of vacuum science & technology. A, Vacuum, surfaces, and films : an official journal of the American Vacuum Society · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Surface Modification of Bacterial Cellulose for Biomedical Applications.International journal of molecular sciences · 2022
    Review
  8. Developments and Ongoing Challenges for Analysis of Surface-Bound Proteins.Annual review of analytical chemistry (Palo Alto, Calif.) · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Multivalent ions and biomolecules: Attempting a comprehensive perspective.Chemphyschem : a European journal of chemical physics and physical chemistry · 2020
    Review
  13. Article
  14. Review
  15. Article
  16. Biological explorations with nanoscale secondary ion mass spectrometry.Journal of analytical atomic spectrometry · 2019
    Article
  17. Article
  18. Article
  19. Surface Analysis: From Single Crystals to Biomaterials.Surface and interface analysis : SIA · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

David G CastnerNational ESCA and Surface Analysis Center for Biomedical Problems, Molecular Engineering and Sciences Institute, Departments of Bioengineering and Chemical Engineering, University of Washington, Box 351653, Seattle, Washington 98195-1653.

Funding

Surface Analysis Facility for Biomedical ProblemsP41EB002027 · NIBIB · UNIVERSITY OF WASHINGTON · PI CASTNER, DAVID G · 2003 to 2019
$17.6M
MS Chemical Imager InstrumentS10OD012309 · OD · UNIVERSITY OF WASHINGTON · PI CASTNER, DAVID G · 2014 to 2014
$1.7M
Cluster Ion Sources for ToF-SIMSS10OD010607 · OD · UNIVERSITY OF WASHINGTON · PI CASTNER, DAVID G · 2012 to 2012
$375k
NIBIB NIH HHS P41 EB002027NIH HHS S10 OD010607NIH HHS S10 OD012309
6 · The paper itself

Abstract

This review describes some of the major advances made in biomedical surface analysis over the past 30-40 years. Starting from a single technique analysis of homogeneous surfaces, it has been developed into a complementary, multitechnique approach for obtaining detailed, comprehensive information about a wide range of surfaces and interfaces of interest to the biomedical community. Significant advances have been made in each surface analysis technique, as well as how the techniques are combined to provide detailed information about biological surfaces and interfaces. The driving force for these advances has been that the surface of a biomaterial is the interface between the biological environment and the biomaterial, and so, the state-of-the-art in instrumentation, experimental protocols, and data analysis methods need to be developed so that the detailed surface structure and composition of biomedical devices can be determined and related to their biological performance. Examples of these advances, as well as areas for future developments, are described for immobilized proteins, complex biomedical surfaces, nanoparticles, and 2D/3D imaging of biological materials.

Indexed as

Biocompatible MaterialsImmobilized ProteinsMicroscopy, Atomic ForceNanoparticlesPolymersQuartz Crystal Microbalance TechniquesSpectrometry, Mass, Secondary IonSurface Plasmon ResonanceSurface PropertiesX-Ray Absorption SpectroscopyBiocompatible MaterialsImmobilized ProteinsPolymers

Identifiers

PMID28438024
PMCPMC5403738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.